These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 9005791)

  • 21. [A new way to fight surgical infections. High activity of trovafloxacin, even against anaerobic bacteria].
    Chirurg; 1998 Jun; 69(6 Suppl):1-4. PubMed ID: 9696895
    [No Abstract]   [Full Text] [Related]  

  • 22. Levofloxacin, a second-generation fluoroquinolone.
    North DS; Fish DN; Redington JJ
    Pharmacotherapy; 1998; 18(5):915-35. PubMed ID: 9758306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Ciprofloxacin in the treatment of infections in oncology patients].
    Dronova OM
    Antibiot Khimioter; 1990 Nov; 35(11):51-4. PubMed ID: 2092640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The use of Maxaquin (lomefloxacin hydrochloride) in the treatment of nonspecific inflammatory diseases and in the prevention of surgical interventions in urology].
    Derevianko II; Lopatkin NA; Khodyreva LA; Kondrat'eva EM
    Urol Nefrol (Mosk); 1998; (5):14-8. PubMed ID: 9820038
    [No Abstract]   [Full Text] [Related]  

  • 25. Critical role of bacterial mixtures in severe surgical infections.
    Rosina M; Germiniani R; Ferla G; Zennaro F; Spinola A; Trabucchi E
    J Chemother; 1989 Jul; 1(4 Suppl):812-4. PubMed ID: 16312651
    [No Abstract]   [Full Text] [Related]  

  • 26. [Comparative evaluation of the effectiveness of ofloxacin in comprehensive treatment of acute inflammatory diseases of the uterus and uterine appendages].
    Savel'eva GM; Evseev AA; Denisova EN
    Antibiot Khimioter; 1996; 41(9):81-3. PubMed ID: 9005794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Ofloxacin in the comprehensive therapy of complicated forms of wound infection].
    Blatun LA; Iakovlev VP; Elagina LV
    Antibiot Khimioter; 1994 Jan; 39(1):33-7. PubMed ID: 8060193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral antibiotic prophylaxis can influence the inflammatory response in aortic aneurysm repair: results of a randomized clinical study.
    Holzheimer RG
    J Chemother; 2003 Apr; 15(2):157-64. PubMed ID: 12797394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical efficacy and cost benefit of oral antimicrobial prophylaxis with levofloxacin on neurological surgery].
    Akiyama Y; Miyazaki T; Daisu M; Yamamoto Y; Shinguu T; Maruyama N; Nagai H; Moritake K
    No Shinkei Geka; 2006 Jul; 34(7):705-12. PubMed ID: 16841706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pharmacokinetics of once-daily oral 400 mg ofloxacin in patients with peritonitis complicating continuous ambulatory peritoneal dialysis.
    McMullin CM; Brown NM; Brown IM; Tomson CR; White LO; Reeves DS; MacGown AP
    J Antimicrob Chemother; 1997 Jun; 39(6):829-31. PubMed ID: 9222057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overview of quinolones in the treatment and prevention of surgical infection.
    Weigelt JA
    Am J Surg; 1998 Dec; 176(6A Suppl):4S-7S. PubMed ID: 9935249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Use of antibiotics in chronic bronchitis].
    Guseĭnov KhIu
    Probl Tuberk; 2000; (1):23-4. PubMed ID: 10750424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo activity of ciprofloxacin, ofloxacin, norfloxacin and pipemidic acid against Escherichia coli infections in mice.
    Obana Y; Nishino T
    Drugs Exp Clin Res; 1989; 15(2):53-8. PubMed ID: 2661182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized prospective study of oral levofloxacin vs intravenous flomoxef prophylaxis in postoperative infection after endoscopic sinus surgery.
    Inoshita A; Yokoi H; Matsumoto F; Yao T; Kawano K; Furukawa M; Ikeda K
    Am J Otolaryngol; 2010; 31(5):360-3. PubMed ID: 20015788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative in vitro activity of imipenem and 15 other antimicrobial agents against clinically important aerobic and anaerobic bacteria.
    Goldstein EJ; Citron DM
    Clin Ther; 1988; 10(5):487-515. PubMed ID: 2856592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Should antimicrobial prophylaxis in colorectal surgery include agents effective against both anaerobic and aerobic microorganisms? A double-blind, multicenter study. The Norwegian Study Group for Colorectal Surgery.
    Surgery; 1985 Apr; 97(4):402-8. PubMed ID: 3885454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Common pathogens of surgical infections and their drug sensitivities].
    Zhang YP
    Zhonghua Wai Ke Za Zhi; 1989 Apr; 27(4):215-6, 253. PubMed ID: 2805989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sparfloxacin and levofloxacin.
    Med Lett Drugs Ther; 1997 Apr; 39(999):41-3. PubMed ID: 9137295
    [No Abstract]   [Full Text] [Related]  

  • 39. Serum bactericidal activities of moxifloxacin and levofloxacin against aerobic and anaerobic intra-abdominal pathogens.
    Stein GE; Schooley S; Tyrrell KL; Citron DM; Nicolau DP; Goldstein EJ
    Anaerobe; 2008 Feb; 14(1):8-12. PubMed ID: 17983770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of ofloxacin--measurement of drug concentration in saliva of patients with impaired renal function.
    Fujita K; Matsuoka N; Takenaka I; Hiraishi K; Yokota T; Asahi T; Tatara K; Yuasa M; Kaifu Y; Kawano A
    Drugs; 1995; 49 Suppl 2():312-3. PubMed ID: 8549345
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.